Meds Apotek Valuation Multiples

Meds Apotek is valued at $45M as of September 2026, a 0.3x revenue multiple. In the last 12 months, Meds Apotek revenue was $113M and Meds Apotek EBITDA was $4M.

Meds Apotek Overview

About Meds Apotek

Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Swedish Medicines Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty, skin care, and animal medicines.


Founded

2017

HQ

Sweden

Employees

N/A

Website

meds.se

Financials (LTM)

Revenue: $113M
EBITDA: $4M

EV

$38M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Meds Apotek Financials

Meds Apotek reported last 12-month revenue of $113M and EBITDA of $4M.

In the same LTM period, Meds Apotek generated $17M in gross profit, $4M in EBITDA, and $2M in net income.

Revenue (LTM)


Meds Apotek P&L

In the most recent fiscal year, Meds Apotek reported revenue of $101M and EBITDA of $2M.

Meds Apotek is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.

See analyst estimates for Meds Apotek
LTMLast FY202320242025202620272028
Revenue$113M$101M$69M$87M$101M
Gross Profit$17M$28M$20M$24M$28M
Gross Margin15%28%29%28%28%
EBITDA$4M$2M($3M)$1M$2M
EBITDA Margin4%2%(4%)2%2%
EBIT Margin2%(0%)(8%)(1%)(0%)
Net Profit$2M$776K($5M)($1M)$776K
Net Margin1%1%(8%)(1%)1%
Net Debt-($4M)---

Financial data powered by Morningstar, Inc.

Meds Apotek Stock Performance

Meds Apotek has current market cap of $45M, and enterprise value of $38M.

Market Cap Evolution


Meds Apotek's stock price is $2.42.

Meds Apotek share price decreased by 8.2% in the last 30 days.

Meds Apotek has an EPS (earnings per share) of $0.04.

See more trading valuation data for Meds Apotek
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$38M$45M-1.6%-8.2%--$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Meds Apotek Valuation Multiples

Meds Apotek trades at 0.3x EV/Revenue multiple, and 9.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Meds Apotek

EV / Revenue (LTM)


Meds Apotek Financial Valuation Multiples

As of September 30, 2026, Meds Apotek has market cap of $45M and EV of $38M.

Meds Apotek has a P/E ratio of 29.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.3x0.4x0.6x0.4x0.4x
EV/EBITDA9.2x21.3x(13.4x)26.6x21.3x
EV/EBIT17.6x(150.9x)(7.3x)(43.0x)(150.9x)
EV/Gross Profit2.3x1.4x1.9x1.6x1.4x
P/E29.2x57.9x(8.4x)(41.1x)57.9x
EV/FCF24.0x(13.1x)(6.2x)29.9x(13.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Meds Apotek Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Meds Apotek Margins & Growth Rates

Meds Apotek grew revenue by 12% and EBITDA by 136% in the last fiscal year.

In the most recent fiscal year, Meds Apotek reported gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.

See estimated margins and future growth rates for Meds Apotek

Meds Apotek Margins

Last FY202420252026202720282029
Gross Margin28%28%28%15%
EBITDA Margin2%2%2%4%
EBIT Margin(0%)(1%)(0%)2%
Net Margin1%(1%)1%2%
FCF Margin(3%)1%(3%)3%

Meds Apotek Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth12%27%16%12%
Gross Profit Growth(40%)24%15%(40%)
EBITDA Growth136%(150%)25%136%
EBIT Growth(1019%)(83%)(71%)(1019%)
Net Profit Growth127%(80%)(171%)127%
FCF Growth(212%)(121%)(329%)(212%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Meds Apotek Operational KPIs

Meds Apotek's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Meds Apotek's Rule of X is 34% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Meds Apotek
LTMLast FY202320242025202620272028
Rule of 4016%16%---
Bessemer Rule of X35%34%---
S&M Expenses to Revenue7%9%--9%
Opex to Revenue-28%36%29%28%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Meds Apotek Competitors

Meds Apotek competitors include Grove Collaborative, Miratap, Sportsman's Warehouse, SunCar, Mister Spex, Koukandekirukun, Angling Direct, Autopedia, Yoho Group Holdings and CMON.

Most Meds Apotek public comparables operate across Pharmacies, Consumer E-commerce and Vertical E-commerce.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Grove Collaborative$174M($9M)0.5x0.5x(9.2x)40.2x
Miratap$106M($3M)0.5x0.5x(18.6x)-
Sportsman's Warehouse$1.2B$2M0.4x0.4x319.2x17.5x
SunCar$489M$9M0.3x0.3x17.0x8.5x
Mister Spex$206M($5M)0.3x0.3x(12.1x)(7.9x)
Koukandekirukun$80M$2M0.5x0.5x22.7x-
Angling Direct$138M$10M0.4x0.4x4.8x5.0x
Autopedia$56M$5M0.4x-5.2x-

This data is available for Pro users. Sign up to see all Meds Apotek competitors and their valuation data.

Start Free Trial

Meds Apotek VC Funding History

Before going public, Meds Apotek raised $46M in total equity funding, across 5 rounds.


Meds Apotek Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jan-21Undisclosed stageM2 Asset Management$20M-Swedish online pharmacy Meds Apotek raised SEK 167 million in a new share issue announced on 21 January 2021, with M2 Asset Management coming in as the largest investor alongside new and existing shareholders. Rutger Arnhult framed the investment as broadening M2 beyond real estate into technology and life science, describing Meds as the fastest-growing company in Sweden's fastest-growing e-commerce segment. Meds reported preliminary revenue of SEK 222 million for 2020, growth of 162 per cent, and used the proceeds to fund further expansion of warehousing and headcount; M2's holding was carried at SEK 123 million at the end of 2021.
Nov-19Undisclosed stageMåns Zelmerlöw$16M--
Jan-19Series ACNI Nordic 5; Inbox Capital$6M-Meds Apotek is a Stockholm-based online pharmacy founded in 2017 that sells beauty and health care products as well as non-prescription medications. On November 1, 2019, the company raised $5.73 million in a funding round with investors including CNI Nordic 5 (listed as Club Network), Inbox Capital, Centripetal, and M2 Asset Management. This round brought Meds Apotek's total funding to $5.73 million.
Mar-18Seed-$4M-Meds Apotek is a Stockholm-based online pharmacy founded in 2017 that sells prescription and over-the-counter medicines, beauty, and health care products with direct delivery and no physical stores. The company raised $5.73M in a funding round on January 11, 2019, led by investors including Inbox Capital. Investors also include Club Network, Centripetal, and M2 Asset Management.
Jul-17Pre-seed-$1M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Meds Apotek

When was Meds Apotek founded?Meds Apotek was founded in 2017.
Where is Meds Apotek headquartered?Meds Apotek is headquartered in Sweden.
Is Meds Apotek publicly listed?Yes, Meds Apotek is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Meds Apotek?Meds Apotek trades under MEDS ticker.
When did Meds Apotek go public?Meds Apotek went public in 2022.
Who are competitors of Meds Apotek?Meds Apotek main competitors include Grove Collaborative, Miratap, Sportsman's Warehouse, SunCar, Mister Spex, Koukandekirukun, Angling Direct, Autopedia, Yoho Group Holdings, CMON.
What is the current market cap of Meds Apotek?Meds Apotek's current market cap is $45M.
What is the current revenue of Meds Apotek?Meds Apotek's last 12 months revenue is $113M.
What is the current revenue growth of Meds Apotek?Meds Apotek revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Meds Apotek?Current revenue multiple of Meds Apotek is 0.3x.
What is the current EBITDA of Meds Apotek?Meds Apotek's last 12 months EBITDA is $4M.
What is Meds Apotek's EBITDA margin?Meds Apotek's last 12 months EBITDA margin is 4%.
What is the current EV/EBITDA multiple of Meds Apotek?Current EBITDA multiple of Meds Apotek is 9.2x.
What is the current FCF of Meds Apotek?Meds Apotek's last 12 months FCF is $2M.
What is Meds Apotek's FCF margin?Meds Apotek's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Meds Apotek?Current FCF multiple of Meds Apotek is 24.0x.
How many companies Meds Apotek has acquired to date?Meds Apotek hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Meds Apotek has invested to date?Meds Apotek hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Meds Apotek

Lists including Meds Apotek

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial